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Diphtheria-like  
Disease Caused  
by Toxigenic  
Corynebacterium 
ulcerans Strain
To the Editor: Toxigenic Coryne-
bacterium ulcerans is an increasingly 
reported cause of diphtheria in the 
United Kingdom and is often associ-
ated with a zoonotic origin (1,2). Here, 
we report a case of diphtheria caused by 
toxigenic C. ulcerans in a woman, 51 
years of age, from Scotland, UK, who 
was admitted to a hospital in August 
2013 with a swollen, sore throat and a 
gray-white membrane over the pharyn-
geal surface. The patient had returned 
from a 2-week family holiday in the 
state of Florida, United States, before 
the admission and also reported recent 
treatment of a pet dog for pharyngitis. 
The patient was believed to have been 
vaccinated against diphtheria during 
childhood. She was immediately ad-
mitted to an isolation ward and treated 
with a combination of clindamycin, 
penicillin, and metronidazole. 
Microscopic examination of the 
throat biofilm (collected by using a 
swab) showed gram-positive bacilli; 
swab samples from the exudative mem-
brane and throat produced small, black 
colonies indicative of Corynebacterium 
spp. on Hoyle medium. Further efforts 
to  identify the strain by using VITEK 
MS and VITEK2 ANC card systems 
(bioMérieux, Marcy l’Etoile, France) 
to evaluate the swab samples suggested 
that the infection was caused by either 
C. ulcerans or C. pseudotuberculosis 
(50% CI). The isolate detected from this 
process was sent to the Streptococcus 
and Diphtheria Reference Unit, Public 
Health England, Colindale, UK, and 
was confirmed to be a toxigenic C. ul-
cerans strain that we designated RAH1. 
Throat swab samples were collected 
from family members of the patient 
and were negative for C. ulcerans. The 
family dog was not tested for presence 
of the organism, although it is known 
that C. ulcerans infections are often of 
a zoonotic nature (1,2). After treatment, 
the patient made a full recovery.
Toxigenic C. ulcerans can pro-
duce both diphtheria-like and Shiga-
like toxins (3); to identify the genetic 
basis of toxin production and other po-
tential virulence factors in this strain, 
a whole genome sequencing approach 
was applied to the isolate. The genome 
was sequenced by using an Ion PGM 
System (Thermo Fischer Scientific, 
Loughborough, Leicestershire, UK) 
and resulting reads (2,965,044 reads, 
≈90× coverage. Data are available on 
GenBank SRA: high-throughput DNA 
and RNA sequence read archive (http://
www.ncbi.nlm.nih.gov/Traces/sra/sra.
cgi?view=search_obj, accession no.: 
SRR1145126) and were mapped onto 
the published genome sequences of 
a Shiga-like toxin–producing clini-
cal isolate 809, asymptomatic canine 
strain BR-AD22 (3), and diphtheria-
like toxin–producing strain 0102 (4). 
Most of the previously identified viru-
lence genes (3,4) were present in the 
patient isolate (Table). The tox gene, 
encoding diphtheria toxin, was pres-
ent, which verified the diphtheria-like 
disease in the patient. The rbp gene, 
responsible for Shiga toxin–like ri-
bosome-binding protein, was absent. 
However, strain RAH1 also possessed 
the venom serine protease gene (vsp2), 
which, in C. ulcerans strain 809, has 
been implicated in the increased viru-
lence in humans. The tox gene was 
present in a prophage that showed 
similarities to ΦCULC809I (3) and 
ΦCULC0102-I (4). Genome-based 
phylogenetic analysis of the RAH1 
strain (ClonalFrame analysis [5]) and 
strains 809, BR-AD22, and 0102 indi-
cates a much wider phylogenetic diver-
sity of C. ulcerans strains than previ-
ously appreciated (data not shown).
This case raises the issue of waning 
vaccine protection in older patients and 
suggests that toxin-mediated coryne-
bacterial disease remains a threat to pub-
lic health. The declining costs of next-
generation sequencing and availability 
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of easy-to-handle bioinformatics tools 
emphasize the suitability of deep-se-
quencing technology for rapid diagnos-
tics and for the development of high-
resolution genotyping. It is time for the 
wider introduction of this technology 
into public health investigations.
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Death of Woman 
with Peripartum 
Influenza B Virus 
Infection and  
Necrotizing  
Pneumonia
To the Editor: Pregnant women 
are at increased risk for severe influen-
za-related complications (1). Bacterial 
pneumonia with Panton-Valentine leu-
kocidin-producing (PVL) Staphylococ-
cus aureus is infrequently described in 
the literature as occurring concurrently 
with influenza B virus infection (2–4). 
Additionally, only 2 occurrences of pe-
ripartum PVL-methicillin-resistant S. 
aureus (MRSA) pneumonia have been 
described (5,6). We report a case of 
influenza B virus and PVL-MRSA co-
infection during pregnancy.
In December 2012, a previously 
healthy pregnant woman, 38 years 
of age, at 37 weeks’ gestation and in 
active labor, sought treatment in a 
New York hospital reporting 2 days 
of fever, productive cough, shortness 
of breath, and pleuritic chest pain. 
Household contacts included children 
with influenza-like illness. The patient 
had declined influenza vaccination 
while receiving prenatal care. On ar-
rival, examination showed that her 
temporal temperature was 101.6°F, 
blood pressure was 122/71 mm Hg, 
pulse was 121 beats per minute, respi-
ratory rate was 40 breaths per minute, 
and oxygen saturation was 89% on 
room air; bilateral inspiratory crack-
les were heard on lung auscultation. 
Rapid influenza screening of a na-
sopharyngeal swab sample by using 
ELISA was negative for influenza A 
and B viruses. Culture of the patient’s 
nares was positive for MRSA coloni-
zation. Laboratory evaluation showed 
leukopenia of 1500/mL, and although 
imaging was limited by the patient’s 
lead apron, a chest radiograph dem-
onstrated bibasilar opacities (Figure, 
panel A). 
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Table.	Virulence	genes	associated	with	Corynebacterium ulcerans present in strain 
RAH1	isolated	from	patient	with	diphtheria-like	disease,	2013, United	Kingdom* 
Gene Strains 
Strain 
RAH1 Potential	function 
tox 0102 P Diphtheria-like	toxin 
rbp 809 A Shiga	toxin–like	ribosome	binding	protein 
cpp 809,	BR-AD22,	0102 P Corynebacterial	protease	CP40,	protective	
antigen	against	caseous	lymphadenitis 
pld 809,	BR-AD22,	0102 P Toxic	phospholipase	D 
spaF 809,	BR-AD22,	0102 P Surface-anchored	protein,	pilus	tip protein 
spaE 809,	BR-AD22,	0102 P Surface-anchored	protein,	minor	pilin	subunit 
spaD 809,	BR-AD22,	0102 P Surface-anchored	protein,	major	pilin	subunit 
spaC 809,	BR-AD22,	0102 P† Surface-anchored	protein,	pilus	tip	protein 
spaB 809,	BR-AD22,	0102 P Surface-anchored	protein,	minor	pilin	subunit 
rpfI 809,	BR-AD22,	0102 P Resuscitation-promoting factor interacting 
protein 
cwlH 809,	BR-AD22,	0102 P Cell	wall–associated	hydrolase 
nanH 809,	BR-AD22,	0102 P Neuraminidase,	glycosyl	hydrolases 
vsp1 809,	BR-AD22 P Venom	serine	protease 
vsp2 809 P Venom	serine	protease 
tspA 809,	BR-AD22 P Trypsin-like	serine	protease 
*P,	present;	A,	absent. 
†700	bp	deletion. 
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